Patents Assigned to Pionyr Immunotherapeutics, Inc.
  • Anti-MARCO antibodies and uses thereof
    Patent number: 11572407
    Abstract: Provided herein are anti-MARCO antibodies. Provided are also methods of generating and using anti-MARCO antibodies.
    Type: Grant
    Filed: November 18, 2021
    Date of Patent: February 7, 2023
    Assignee: PIONYR IMMUNOTHERAPEUTICS, INC.
    Inventors: Nadine Jahchan, Michel Streuli, Xi Yang, Linda Liang, Venkataraman Sriram, Joshua Pollack, Kara Mojica, Vladislava Juric, Linnea Haeggblom, Leonard G. Presta, Sayantan Mitra
  • Anti-TREM2 antibodies and related methods
    Patent number: 11505602
    Abstract: Provided herein are anti-TREM2 antibodies and related methods of making and using anti-TREM2 antibodies. Also provided are methods and compositions for enhancing an immune response and/or for the treatment of an immune-related condition in an individual, e.g., cancer, comprising killing, disabling, or depleting non-stimulatory myeloid cells using an anti-TREM2 antibody or antigen binding fragment thereof.
    Type: Grant
    Filed: October 14, 2019
    Date of Patent: November 22, 2022
    Assignee: PIONYR IMMUNOTHERAPEUTICS, INC.
    Inventors: Michel Streuli, Venkataraman Sriram, Aritra Pal, Leonard G. Presta
  • Anti-TREM1 antibodies and related methods
    Patent number: 10836828
    Abstract: Provided herein are anti-TREM1 antibodies and related methods of making and using anti-TREM1 antibodies. Also provided are methods and compositions for enhancing an immune response and/or for the treatment of an immune-related condition in an individual, e.g., cancer, comprising killing, disabling, or depleting non-stimulatory myeloid cells using an anti-TREM1 antibody or antigen binding fragment thereof.
    Type: Grant
    Filed: April 17, 2020
    Date of Patent: November 17, 2020
    Assignee: PIONYR IMMUNOTHERAPEUTICS, INC.
    Inventors: Christopher Chan, Aritra Pal, Venkataraman Sriram, Leonard G. Presta, Tiep Tu Le, Linda Liang
  • Anti-TREM2 antibodies and related methods
    Patent number: 10508148
    Abstract: Provided herein are anti-TREM2 antibodies and related methods of making and using anti-TREM2 antibodies. Also provided are methods and compositions for enhancing an immune response and/or for the treatment of an immune-related condition in an individual, e.g., cancer, comprising killing, disabling, or depleting non-stimulatory myeloid cells using an anti-TREM2 antibody or antigen binding fragment thereof.
    Type: Grant
    Filed: May 9, 2019
    Date of Patent: December 17, 2019
    Assignee: Pionyr Immunotherapeutics, Inc.
    Inventors: Michel Streuli, Venkataraman Sriram, Aritra Pal, Leonard G. Presta